Factors that could cause these forward-looking statements to differ from actual results include adverse regulatory determinations related to the trial, competitive factors related to the drug product, economic factors including RedHill's ability to finance the development and commercialization of the product, and other risks and uncertainties discussed in the company's periodic reports on Form 10-